iBio, Inc.
USD1.36
-0.01 (-0.73%)
CEO
Martin Brenner
IPO Date
2008-08-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.38
Prev. Close
$1.37
Day Low
$1.35
Day High
$1.40
52W Low
$0.56
52W High
$3.82
Market Cap
$0.02B
Volume
0.03M
| 0 |
| $0.00 |
| 27 Mar 2026 | Banjak Marc | Chief Legal Officer | P-Purchase | Acquired | 12,500 | $1.64 |
| 27 Mar 2026 | Banjak Marc | Chief Legal Officer | P-Purchase | Acquired | 1,434 | $1.76 |
| 23 Mar 2026 | Duran Felipe | Chief Financial Officer | P-Purchase | Acquired | 24,835 | $2.02 |
| 23 Mar 2026 | Brenner Martin | director, officer: See Remarks | P-Purchase | Acquired | 12,336 | $2.02 |
| 30 Jan 2026 | Banjak Marc | Chief Legal Officer | A-Award | Acquired | 146,000 | $2.23 |
| 30 Jan 2026 | Duran Felipe | Chief Financial Officer | A-Award | Acquired | 179,000 | $2.23 |
| 30 Jan 2026 | Brenner Martin | director, officer: See Remarks | A-Award | Acquired | 479,000 | $2.23 |
| 24 Nov 2025 | Schimmelpennink Evert B. | director | A-Award | Acquired | 13,500 | $1.00 |